Adjuvant treatments of breast cancer increase the risk of depressive disorders: A population-based study. [electronic resource]
Producer: 20151228Description: 44-9 p. digitalISSN:- 1573-2517
- Adult
- Anastrozole
- Androstadienes -- therapeutic use
- Antineoplastic Agents -- therapeutic use
- Aromatase Inhibitors -- therapeutic use
- Breast Neoplasms -- epidemiology
- Chemotherapy, Adjuvant
- Depressive Disorder -- epidemiology
- Female
- Follow-Up Studies
- Humans
- Kaplan-Meier Estimate
- Letrozole
- Middle Aged
- Nitriles -- therapeutic use
- Population Surveillance -- methods
- Proportional Hazards Models
- Retrospective Studies
- Risk
- Taiwan -- epidemiology
- Tamoxifen -- therapeutic use
- Trastuzumab -- therapeutic use
- Triazoles -- therapeutic use
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.